| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 13 | 2025 | 1378 | 3.080 |
Why?
|
| Transcription Factors | 25 | 2025 | 1561 | 2.930 |
Why?
|
| Acupuncture Therapy | 7 | 2022 | 18 | 2.850 |
Why?
|
| Cancer Survivors | 8 | 2023 | 131 | 2.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2025 | 441 | 2.540 |
Why?
|
| Integrative Medicine | 5 | 2022 | 34 | 2.450 |
Why?
|
| Hedgehog Proteins | 15 | 2017 | 116 | 2.230 |
Why?
|
| Breast Neoplasms | 13 | 2023 | 1235 | 2.030 |
Why?
|
| Integrative Oncology | 3 | 2022 | 3 | 1.980 |
Why?
|
| Medical Oncology | 6 | 2019 | 70 | 1.880 |
Why?
|
| Nuclear Proteins | 10 | 2025 | 793 | 1.620 |
Why?
|
| DNA-Binding Proteins | 12 | 2025 | 1226 | 1.530 |
Why?
|
| Carcinogenesis | 5 | 2025 | 135 | 1.480 |
Why?
|
| Aromatase Inhibitors | 3 | 2019 | 11 | 1.480 |
Why?
|
| Trans-Activators | 12 | 2022 | 321 | 1.260 |
Why?
|
| Acupuncture | 2 | 2020 | 4 | 1.230 |
Why?
|
| Signal Transduction | 36 | 2025 | 3170 | 1.210 |
Why?
|
| Mesoderm | 6 | 2017 | 89 | 1.080 |
Why?
|
| Phosphoproteins | 12 | 2025 | 224 | 1.070 |
Why?
|
| Cell Cycle Proteins | 8 | 2025 | 403 | 1.060 |
Why?
|
| Complementary Therapies | 4 | 2021 | 63 | 1.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2024 | 128 | 0.950 |
Why?
|
| Pyroptosis | 1 | 2026 | 38 | 0.920 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2025 | 9 | 0.900 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2014 | 48 | 0.890 |
Why?
|
| Bereavement | 1 | 2025 | 18 | 0.880 |
Why?
|
| Music Therapy | 1 | 2025 | 15 | 0.880 |
Why?
|
| Sarcoma | 1 | 2025 | 36 | 0.880 |
Why?
|
| Neoplasm Proteins | 2 | 2026 | 286 | 0.860 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 64 | 0.850 |
Why?
|
| Survivors | 3 | 2023 | 189 | 0.850 |
Why?
|
| Narration | 1 | 2025 | 54 | 0.840 |
Why?
|
| Pancreatic Neoplasms | 3 | 2024 | 354 | 0.830 |
Why?
|
| Music | 1 | 2025 | 75 | 0.830 |
Why?
|
| Mice | 41 | 2025 | 11184 | 0.830 |
Why?
|
| Gastrointestinal Tract | 3 | 2017 | 187 | 0.800 |
Why?
|
| Adaptation, Psychological | 1 | 2025 | 278 | 0.760 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2022 | 1 | 0.740 |
Why?
|
| Animals | 53 | 2026 | 21492 | 0.740 |
Why?
|
| Humans | 55 | 2026 | 65843 | 0.730 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 290 | 0.710 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 65 | 0.690 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 142 | 0.660 |
Why?
|
| Parents | 1 | 2025 | 418 | 0.650 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 48 | 0.650 |
Why?
|
| Quality of Life | 5 | 2023 | 1266 | 0.640 |
Why?
|
| Cell Differentiation | 9 | 2025 | 1391 | 0.640 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 50 | 0.610 |
Why?
|
| Intestines | 3 | 2020 | 184 | 0.610 |
Why?
|
| Transcription, Genetic | 7 | 2024 | 911 | 0.610 |
Why?
|
| Arthralgia | 1 | 2019 | 60 | 0.570 |
Why?
|
| Wnt Proteins | 11 | 2013 | 104 | 0.570 |
Why?
|
| Mice, Transgenic | 14 | 2025 | 1292 | 0.560 |
Why?
|
| Nerve Tissue Proteins | 6 | 2016 | 428 | 0.560 |
Why?
|
| Fatigue | 2 | 2019 | 114 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 737 | 0.550 |
Why?
|
| Receptors, G-Protein-Coupled | 6 | 2013 | 141 | 0.540 |
Why?
|
| Stem Cells | 5 | 2020 | 278 | 0.540 |
Why?
|
| Zinc Finger Protein Gli2 | 4 | 2024 | 26 | 0.540 |
Why?
|
| Low Back Pain | 1 | 2019 | 113 | 0.530 |
Why?
|
| Epithelium | 1 | 2017 | 100 | 0.520 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 128 | 0.510 |
Why?
|
| Zinc Finger Protein GLI1 | 6 | 2022 | 31 | 0.510 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 50 | 0.500 |
Why?
|
| Chronic Pain | 1 | 2019 | 157 | 0.490 |
Why?
|
| Melanoma | 1 | 2019 | 335 | 0.470 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 309 | 0.470 |
Why?
|
| Rhabdomyosarcoma | 2 | 2013 | 15 | 0.470 |
Why?
|
| Transcription Factor AP-1 | 1 | 2016 | 46 | 0.470 |
Why?
|
| beta Catenin | 4 | 2013 | 100 | 0.460 |
Why?
|
| Hot Flashes | 3 | 2020 | 102 | 0.460 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2022 | 37 | 0.450 |
Why?
|
| Muscle Proteins | 1 | 2016 | 117 | 0.440 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 345 | 0.440 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1044 | 0.440 |
Why?
|
| Female | 26 | 2025 | 34424 | 0.430 |
Why?
|
| Cell Lineage | 3 | 2013 | 282 | 0.430 |
Why?
|
| Zebrafish Proteins | 8 | 2004 | 171 | 0.430 |
Why?
|
| Medicare | 1 | 2019 | 629 | 0.420 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 357 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2024 | 588 | 0.420 |
Why?
|
| Proteins | 9 | 2005 | 764 | 0.420 |
Why?
|
| Repressor Proteins | 5 | 2021 | 351 | 0.420 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2012 | 344 | 0.410 |
Why?
|
| GTP-Binding Proteins | 3 | 1998 | 93 | 0.410 |
Why?
|
| Cell Movement | 1 | 2016 | 484 | 0.400 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2013 | 14 | 0.390 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2013 | 10 | 0.390 |
Why?
|
| Body Patterning | 2 | 2014 | 94 | 0.380 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 1572 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2023 | 205 | 0.370 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 645 | 0.360 |
Why?
|
| Genes, ras | 1 | 2012 | 28 | 0.360 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 375 | 0.360 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2002 | 128 | 0.360 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2025 | 211 | 0.350 |
Why?
|
| Hemangioendothelioma, Epithelioid | 2 | 2021 | 7 | 0.340 |
Why?
|
| Adult | 11 | 2025 | 17579 | 0.330 |
Why?
|
| Biomedical Research | 3 | 2019 | 263 | 0.330 |
Why?
|
| Zinc Finger Protein Gli3 | 3 | 2016 | 10 | 0.330 |
Why?
|
| Mammals | 2 | 2010 | 222 | 0.320 |
Why?
|
| Drosophila melanogaster | 4 | 2021 | 563 | 0.310 |
Why?
|
| Receptors, LDL | 4 | 2004 | 35 | 0.310 |
Why?
|
| Smoothened Receptor | 6 | 2013 | 27 | 0.300 |
Why?
|
| Receptors, Cell Surface | 4 | 2014 | 432 | 0.300 |
Why?
|
| Intestinal Mucosa | 4 | 2019 | 254 | 0.300 |
Why?
|
| Gene Expression Regulation | 4 | 2005 | 1635 | 0.300 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2009 | 4 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2009 | 19 | 0.290 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 158 | 0.290 |
Why?
|
| Middle Aged | 11 | 2025 | 18501 | 0.290 |
Why?
|
| Vertebrates | 1 | 2009 | 43 | 0.290 |
Why?
|
| Weight Gain | 1 | 2010 | 165 | 0.280 |
Why?
|
| Pain Management | 2 | 2022 | 174 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 518 | 0.280 |
Why?
|
| Cell Transdifferentiation | 2 | 2025 | 16 | 0.280 |
Why?
|
| Extremities | 1 | 2009 | 63 | 0.280 |
Why?
|
| Protein Binding | 6 | 2022 | 1638 | 0.280 |
Why?
|
| 3T3 Cells | 10 | 2002 | 111 | 0.280 |
Why?
|
| Neoplasms, Experimental | 2 | 2009 | 77 | 0.260 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2194 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 663 | 0.250 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 174 | 0.250 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2013 | 35 | 0.250 |
Why?
|
| United States | 5 | 2022 | 8189 | 0.250 |
Why?
|
| Acylation | 1 | 2026 | 16 | 0.240 |
Why?
|
| Culturally Competent Care | 2 | 2023 | 17 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2329 | 0.230 |
Why?
|
| Neurons | 3 | 2025 | 935 | 0.230 |
Why?
|
| Mullerian Ducts | 1 | 2025 | 5 | 0.230 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2025 | 3 | 0.230 |
Why?
|
| Zona Glomerulosa | 1 | 2025 | 1 | 0.230 |
Why?
|
| Adrenal Cortex | 1 | 2025 | 3 | 0.230 |
Why?
|
| Myofibroblasts | 1 | 2025 | 22 | 0.230 |
Why?
|
| Age Factors | 3 | 2019 | 1595 | 0.220 |
Why?
|
| Neoplastic Stem Cells | 3 | 2016 | 196 | 0.220 |
Why?
|
| Grief | 1 | 2025 | 19 | 0.220 |
Why?
|
| Immunoblotting | 2 | 2017 | 202 | 0.220 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 2739 | 0.220 |
Why?
|
| Drosophila Proteins | 3 | 2018 | 762 | 0.220 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 2790 | 0.220 |
Why?
|
| Child | 3 | 2025 | 4652 | 0.220 |
Why?
|
| Disease Progression | 2 | 2019 | 1229 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 118 | 0.210 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 1980 | 0.210 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2002 | 62 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2021 | 5834 | 0.200 |
Why?
|
| Postmenopause | 2 | 2019 | 241 | 0.200 |
Why?
|
| Young Adult | 4 | 2025 | 4883 | 0.200 |
Why?
|
| Integrin alpha6beta1 | 2 | 2015 | 34 | 0.200 |
Why?
|
| Aged | 5 | 2025 | 15147 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2025 | 152 | 0.190 |
Why?
|
| Integrases | 3 | 2009 | 41 | 0.190 |
Why?
|
| Hope | 1 | 2022 | 10 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2025 | 593 | 0.190 |
Why?
|
| Antisocial Personality Disorder | 1 | 2022 | 38 | 0.190 |
Why?
|
| Interleukin-33 | 1 | 2022 | 19 | 0.180 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 34 | 0.180 |
Why?
|
| Mentoring | 1 | 2023 | 64 | 0.180 |
Why?
|
| Pain | 2 | 2022 | 400 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 542 | 0.180 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5682 | 0.180 |
Why?
|
| Logistic Models | 2 | 2019 | 1274 | 0.180 |
Why?
|
| Microglia | 1 | 2025 | 254 | 0.180 |
Why?
|
| Risk Factors | 3 | 2019 | 5475 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 178 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2021 | 312 | 0.180 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 89 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 133 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 213 | 0.170 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 18 | 0.170 |
Why?
|
| Mitochondria | 1 | 2025 | 416 | 0.170 |
Why?
|
| Alleles | 4 | 2020 | 455 | 0.170 |
Why?
|
| Cell Nucleus | 2 | 2018 | 634 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2021 | 59 | 0.170 |
Why?
|
| COS Cells | 5 | 2002 | 180 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 81 | 0.160 |
Why?
|
| Inflammation | 2 | 2025 | 1198 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2020 | 3 | 0.160 |
Why?
|
| Social Support | 1 | 2023 | 394 | 0.160 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2020 | 8 | 0.160 |
Why?
|
| DNA Transposable Elements | 1 | 2021 | 160 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 33 | 0.160 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 84 | 0.160 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2019 | 1 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 113 | 0.150 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2019 | 6 | 0.150 |
Why?
|
| Phosphorylation | 6 | 2019 | 963 | 0.150 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2019 | 12 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2019 | 129 | 0.150 |
Why?
|
| Male | 11 | 2025 | 31410 | 0.150 |
Why?
|
| SOXC Transcription Factors | 2 | 2022 | 9 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 216 | 0.150 |
Why?
|
| Erdheim-Chester Disease | 1 | 2019 | 2 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 173 | 0.150 |
Why?
|
| Survivorship | 1 | 2019 | 14 | 0.150 |
Why?
|
| Melanocytes | 1 | 2019 | 77 | 0.140 |
Why?
|
| Symptom Assessment | 1 | 2019 | 48 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 411 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 211 | 0.140 |
Why?
|
| Mice, 129 Strain | 2 | 2020 | 41 | 0.140 |
Why?
|
| Internet | 2 | 2019 | 472 | 0.140 |
Why?
|
| Reproductive Health | 1 | 2018 | 25 | 0.140 |
Why?
|
| Kidney | 1 | 2021 | 460 | 0.140 |
Why?
|
| Telemedicine | 1 | 2023 | 379 | 0.140 |
Why?
|
| Yeasts | 1 | 2018 | 47 | 0.140 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 29 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2025 | 2168 | 0.130 |
Why?
|
| Web Browser | 1 | 2017 | 7 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2019 | 153 | 0.130 |
Why?
|
| Comprehensive Health Care | 1 | 2017 | 21 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 218 | 0.130 |
Why?
|
| Medulloblastoma | 2 | 2008 | 13 | 0.130 |
Why?
|
| Acyltransferases | 1 | 2017 | 33 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2019 | 617 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 439 | 0.130 |
Why?
|
| Menopause, Premature | 1 | 2017 | 25 | 0.130 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2016 | 2 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 67 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 375 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 32 | 0.120 |
Why?
|
| Transfection | 6 | 2016 | 700 | 0.120 |
Why?
|
| Social Media | 1 | 2019 | 129 | 0.120 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2016 | 20 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2013 | 157 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 554 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2018 | 506 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 32 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 141 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2020 | 3340 | 0.120 |
Why?
|
| Women's Health | 1 | 2019 | 376 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 462 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2021 | 92 | 0.120 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 13 | 0.120 |
Why?
|
| RNA Interference | 3 | 2016 | 647 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 264 | 0.120 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2015 | 3 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2016 | 28 | 0.120 |
Why?
|
| Disease Management | 1 | 2017 | 235 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2016 | 38 | 0.120 |
Why?
|
| Amino Acid Sequence | 6 | 2013 | 1590 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 46 | 0.110 |
Why?
|
| Mutation | 4 | 2019 | 2674 | 0.110 |
Why?
|
| Adolescent | 2 | 2025 | 6368 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 464 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 103 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2016 | 267 | 0.110 |
Why?
|
| Receptors, Notch | 2 | 2016 | 110 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 289 | 0.110 |
Why?
|
| Macrophages | 1 | 2020 | 1042 | 0.110 |
Why?
|
| Medicaid | 1 | 2019 | 379 | 0.110 |
Why?
|
| Serum Response Factor | 3 | 1998 | 5 | 0.110 |
Why?
|
| Time Factors | 4 | 2017 | 3779 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 899 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 124 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 741 | 0.110 |
Why?
|
| Laminin | 1 | 2015 | 81 | 0.110 |
Why?
|
| Menopause | 1 | 2017 | 257 | 0.100 |
Why?
|
| Prevalence | 1 | 2018 | 1454 | 0.100 |
Why?
|
| Health Promotion | 1 | 2018 | 524 | 0.100 |
Why?
|
| PAX7 Transcription Factor | 1 | 2013 | 9 | 0.100 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2013 | 15 | 0.100 |
Why?
|
| Rhabdomyoma | 1 | 2013 | 2 | 0.100 |
Why?
|
| Genome, Human | 1 | 2016 | 238 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2014 | 154 | 0.100 |
Why?
|
| Muscle Neoplasms | 1 | 2013 | 9 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 148 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 29 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2019 | 757 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 108 | 0.100 |
Why?
|
| Base Sequence | 1 | 2016 | 1332 | 0.100 |
Why?
|
| Regeneration | 1 | 2014 | 127 | 0.100 |
Why?
|
| Exocrine Glands | 1 | 2013 | 1 | 0.100 |
Why?
|
| Edar Receptor | 1 | 2013 | 1 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 128 | 0.100 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 173 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 784 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 426 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 30 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 233 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 66 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2016 | 1583 | 0.090 |
Why?
|
| Neuropilin-2 | 1 | 2013 | 40 | 0.090 |
Why?
|
| Hair | 1 | 2013 | 81 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 297 | 0.090 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 37 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 243 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 611 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2013 | 129 | 0.090 |
Why?
|
| Luciferases | 3 | 2002 | 107 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 268 | 0.090 |
Why?
|
| Protein Transport | 2 | 2003 | 405 | 0.090 |
Why?
|
| Tamoxifen | 2 | 2016 | 42 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2011 | 23 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1193 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2002 | 27 | 0.080 |
Why?
|
| Gastrula | 1 | 2010 | 13 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2010 | 17 | 0.080 |
Why?
|
| Philadelphia | 1 | 2010 | 24 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 436 | 0.080 |
Why?
|
| Axin Protein | 4 | 2007 | 10 | 0.080 |
Why?
|
| Genes, Reporter | 4 | 2007 | 257 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 789 | 0.080 |
Why?
|
| Organogenesis | 1 | 2010 | 40 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 54 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 799 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 527 | 0.070 |
Why?
|
| Histones | 2 | 2024 | 497 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 135 | 0.070 |
Why?
|
| Polydactyly | 1 | 2009 | 2 | 0.070 |
Why?
|
| Ectoderm | 1 | 2009 | 12 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2009 | 17 | 0.070 |
Why?
|
| Chick Embryo | 1 | 2009 | 46 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 413 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2009 | 128 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 195 | 0.070 |
Why?
|
| Outpatients | 1 | 2010 | 143 | 0.070 |
Why?
|
| Genotype | 3 | 2020 | 676 | 0.070 |
Why?
|
| Thrombin | 2 | 1998 | 23 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2009 | 110 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 503 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2016 | 491 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 2 | 1998 | 69 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 690 | 0.070 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 3 | 2004 | 4 | 0.070 |
Why?
|
| LDL-Receptor Related Proteins | 3 | 2004 | 5 | 0.070 |
Why?
|
| Cell Line | 3 | 2011 | 2031 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2013 | 302 | 0.070 |
Why?
|
| Phenotype | 3 | 2020 | 1236 | 0.070 |
Why?
|
| Patched Receptors | 3 | 2014 | 10 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2021 | 344 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 53 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2009 | 304 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 3506 | 0.060 |
Why?
|
| Stomach | 1 | 2007 | 87 | 0.060 |
Why?
|
| Morphogenesis | 1 | 2007 | 120 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2003 | 719 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2021 | 1030 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2001 | 46 | 0.060 |
Why?
|
| Spleen | 1 | 2007 | 476 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 154 | 0.060 |
Why?
|
| Xenopus Proteins | 2 | 2003 | 38 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 277 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 41 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2004 | 672 | 0.060 |
Why?
|
| Chimera | 1 | 2005 | 44 | 0.060 |
Why?
|
| Granulosa Cells | 1 | 2025 | 18 | 0.060 |
Why?
|
| Doxycycline | 1 | 2005 | 47 | 0.060 |
Why?
|
| Ovary | 1 | 2025 | 105 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 105 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 365 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 89 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2007 | 414 | 0.050 |
Why?
|
| Dishevelled Proteins | 5 | 2003 | 6 | 0.050 |
Why?
|
| Gene Expression | 2 | 2013 | 856 | 0.050 |
Why?
|
| Patched-1 Receptor | 2 | 2014 | 13 | 0.050 |
Why?
|
| Binding Sites | 3 | 2016 | 922 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2025 | 926 | 0.050 |
Why?
|
| Face | 1 | 2004 | 36 | 0.050 |
Why?
|
| Neural Crest | 1 | 2004 | 30 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 216 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2016 | 664 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1569 | 0.050 |
Why?
|
| Cell Death | 1 | 2025 | 289 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 100 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2005 | 273 | 0.050 |
Why?
|
| Ovum | 1 | 2003 | 63 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 526 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 116 | 0.050 |
Why?
|
| Lipoylation | 1 | 2022 | 5 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2010 | 2116 | 0.050 |
Why?
|
| Crystallization | 1 | 2022 | 97 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 77 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2002 | 3 | 0.040 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2002 | 5 | 0.040 |
Why?
|
| Lac Operon | 1 | 2002 | 26 | 0.040 |
Why?
|
| Cicatrix | 1 | 2022 | 62 | 0.040 |
Why?
|
| Point Mutation | 1 | 2002 | 169 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 172 | 0.040 |
Why?
|
| Bone Density | 1 | 2002 | 142 | 0.040 |
Why?
|
| Cysteine | 1 | 2001 | 108 | 0.040 |
Why?
|
| Biological Variation, Population | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cadherins | 1 | 2021 | 90 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 133 | 0.040 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2020 | 11 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2020 | 38 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 298 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 423 | 0.040 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 4 | 2000 | 10 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 238 | 0.040 |
Why?
|
| Sexual Health | 1 | 2018 | 8 | 0.040 |
Why?
|
| Endothelins | 1 | 1998 | 3 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1998 | 7 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1998 | 9 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 1998 | 26 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Epidermis | 1 | 2018 | 35 | 0.040 |
Why?
|
| Fertility | 1 | 2018 | 85 | 0.030 |
Why?
|
| Myocardium | 1 | 2020 | 302 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1998 | 142 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 746 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 32 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 84 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1998 | 301 | 0.030 |
Why?
|
| Affect | 1 | 2019 | 132 | 0.030 |
Why?
|
| Contraception | 1 | 2018 | 72 | 0.030 |
Why?
|
| Memory | 1 | 2019 | 124 | 0.030 |
Why?
|
| Musculoskeletal Manipulations | 1 | 2017 | 1 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 161 | 0.030 |
Why?
|
| Mind-Body Therapies | 1 | 2017 | 10 | 0.030 |
Why?
|
| Text Messaging | 1 | 2018 | 98 | 0.030 |
Why?
|
| Premenopause | 1 | 2017 | 60 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 132 | 0.030 |
Why?
|
| Arsenicals | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 3 | 2007 | 203 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2016 | 34 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 19 | 0.030 |
Why?
|
| Oxides | 1 | 2016 | 36 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 747 | 0.030 |
Why?
|
| Kinetics | 1 | 1998 | 758 | 0.030 |
Why?
|
| Digestion | 1 | 2018 | 163 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 643 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1294 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2016 | 6 | 0.030 |
Why?
|
| Receptor, Notch3 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 261 | 0.030 |
Why?
|
| Leuprolide | 1 | 2016 | 18 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2017 | 134 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 65 | 0.030 |
Why?
|
| Androstadienes | 1 | 2016 | 43 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 44 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 167 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1122 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 82 | 0.030 |
Why?
|
| Triazoles | 1 | 2016 | 63 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 589 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 132 | 0.030 |
Why?
|
| Cilia | 1 | 2016 | 156 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 223 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2001 | 391 | 0.030 |
Why?
|
| Life Style | 1 | 2017 | 324 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 489 | 0.030 |
Why?
|
| Health Personnel | 1 | 2019 | 391 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 993 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 588 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 518 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 859 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1793 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 811 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 260 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2016 | 189 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 324 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 922 | 0.030 |
Why?
|
| Health Behavior | 1 | 2017 | 485 | 0.020 |
Why?
|
| Ligands | 1 | 2015 | 414 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 62 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2500 | 0.020 |
Why?
|
| Diet | 1 | 2017 | 540 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 451 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 4 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 11 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 901 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 161 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 198 | 0.020 |
Why?
|
| Scalp | 1 | 2013 | 30 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 48 | 0.020 |
Why?
|
| Haplotypes | 1 | 2013 | 137 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 238 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 593 | 0.020 |
Why?
|
| Xenopus | 2 | 2003 | 55 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2011 | 14 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2011 | 98 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 65 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2651 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 312 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 182 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 351 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 970 | 0.020 |
Why?
|
| Glycogen Synthase Kinases | 2 | 1999 | 3 | 0.020 |
Why?
|
| Wnt1 Protein | 2 | 1999 | 12 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 30 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 1438 | 0.020 |
Why?
|
| Cerebrum | 1 | 2008 | 16 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 710 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 42 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 116 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1717 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2007 | 4 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 2089 | 0.020 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2007 | 5 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 4 | 0.020 |
Why?
|
| Microvilli | 1 | 2007 | 6 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 6 | 0.020 |
Why?
|
| Endoderm | 1 | 2007 | 47 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 35 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 213 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 41 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 84 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 193 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 113 | 0.020 |
Why?
|
| Skull | 1 | 2004 | 52 | 0.010 |
Why?
|
| Mandible | 1 | 2002 | 8 | 0.010 |
Why?
|
| Palate | 1 | 2002 | 7 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2002 | 11 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 56 | 0.010 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2001 | 3 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 182 | 0.010 |
Why?
|
| Pedigree | 1 | 2002 | 193 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 157 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2002 | 190 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 154 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2000 | 85 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 559 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 172 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 345 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 357 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 268 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1148 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1999 | 377 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 1161 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 793 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1503 | 0.010 |
Why?
|